Phospho-Bad (S136) Polyclonal Antibody, 50ul Immune Repertoire Sequencing Evidence indicates that mutations in

Evidence indicates that mutations in this gene are responsible for the primary defects in patients with progressive myoclonic epilepsy (EPM1)

The assembled v-SNARE/t-SNARE complex consists of a bundle of four helices

Single package and bulk packaging are available for different customer requirements

Plays a role in positive regulation through interaction with Src family tyrosine kinases and may also act as an inhibitory receptor by recruiting cytoplasmic phosphatases via their SH2 domains that block signal transduction through dephosphorylation of signaling molecules

Orphan receptor with constitutive G(i) signaling activity that activate cyclic AMP

Phospho-Bad (S136) Polyclonal Antibody, 50ul Immune Repertoire Sequencing Evidence indicates that mutations inBCL2 associated agonist of cell death encoded by BAD is a member of the BCL 2 family. BCL 2 family members are known to be regulators of programmed cell death. BCL2 associated agonist of cell death positively regulates cell apoptosis by forming heterodimers with BCL xL and BCL 2, and reversing their death repressor activity. Proapoptotic activity of BCL2 associated agonist of cell death is regulated through its phosphorylation. Protein kinases AKT and